Optimizing Treatment Outcomes with Long-acting Injectables
by Dr. Howard Margolese | Associate Professor, Department of Psychiatry, McGill University | Program director, McGill Clinical Pharmacology & Toxicology residency program |
Director, PEPP-MUHC first episode psychosis program, EPSSP (Early Psychosis and Schizophrenia Spectrum Program) | Director, Clinical Psychopharmacology and Therapeutics Unit